))
Health411 - Sickle Cell Gene Editing Therapy
Manage episode 391250832 series 3236776
Content provided by Dr. Jonathan Karp. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Jonathan Karp or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode of Health411, host Dr. Jonathan Karp and producers Daniel Geller and Josh Brewer delve into the groundbreaking world of Casgevy, the first FDA-approved CRISPR/Cas9-based treatment for sickle cell anemia. They explore the science behind this revolutionary gene-editing therapy, its potential implications for patients, and the ethical considerations surrounding genetic interventions in healthcare.
233 episodes
Share
